Yubo International Biotech Limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 0.00143 million compared to USD 0.00797 million a year ago. Net loss was USD 0.367327 million compared to USD 0.491559 million a year ago.
For the six months, sales was USD 0.15388 million compared to USD 0.023183 million a year ago. Net loss was USD 0.683994 million compared to USD 1.07 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.